Caxton Corp as of Dec. 31, 2024
Portfolio Holdings for Caxton Corp
Caxton Corp holds 15 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 41.1 | $6.8M | 2.0M | 3.39 | |
| Rezolute Com New (RZLT) | 38.8 | $6.5M | 1.3M | 4.90 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 9.9 | $1.7M | 2.8k | 586.08 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 3.1 | $514k | 1.1k | 453.27 | |
| Spdr Gold Tr Gold Shs (GLD) | 1.7 | $283k | 1.2k | 242.15 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.4 | $237k | 34k | 6.96 | |
| Bicara Therapeutics (BCAX) | 1.1 | $191k | 11k | 17.42 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $118k | 18k | 6.58 | |
| Kyverna Therapeutics (KYTX) | 0.5 | $86k | 23k | 3.74 | |
| Compass Therapeutics (CMPX) | 0.4 | $63k | 44k | 1.45 | |
| Cardiff Oncology (CRDF) | 0.3 | $58k | 13k | 4.34 | |
| Inhibikase Therapeutics Com New (IKT) | 0.3 | $53k | 16k | 3.25 | |
| Glycomimetics | 0.3 | $51k | 204k | 0.25 | |
| Context Therapeutics (CNTX) | 0.1 | $19k | 18k | 1.05 | |
| Adicet Bio (ACET) | 0.1 | $17k | 18k | 0.96 |
